Performance analysis of Propanc Biopharma (PPCB)
Annual Return
Over the past 3 years, PPCB has had an average annual return of +0%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, PPCB has had an average annual return of +0%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, PPCB has had an average annual return of -84.08%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 12, 2012, PPCB has had an average annual return of -77.60%, underperforming the benchmark SPY, which returned +15.11% annual.
| 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -75.00% | -92.98% | -69.02% | +1,740% | -98.48% | -90.10% | -33.55% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | +0% | +0% | |||||||||||
| 2018 | -0% | -25.00% | +0% | -33.33% | +0% | -50.00% | +0% | +100% | +0% | -50.00% | +0% | +0% | -75.00% |
| 2017 | +21.05% | +1.45% | -14.29% | -13.33% | -28.85% | -29.73% | -57.69% | -27.27% | +12.50% | -66.67% | +0% | +33.33% | -92.98% |
Drawdown analysis of Propanc Biopharma (PPCB)
The maximum drawdown for the PPCB was -99.99%, occurring on Jun 28, 2018. This drawdown has not yet recovered.
The current PPCB drawdown is -99.99%.
Since Nov 12, 2012 PPCB has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Nov 12, 2012 | 1409 | Jun 28, 2018 | Ongoing | Ongoing | Ongoing |